REVIEW PAPER ON LEPROSY
Journal Title: World Journal of Pharmaceutical Research - Year 2018, Vol 7, Issue 9
Abstract
Leprosy is also known as Hansen’s disease, is a chronic infectious disease caused by Mycobacterium leprous, a microorganism has predilection for the skin and nerves. The disease is clinically characterized by one or more of the three cardinal signs Hypo pigmented or eythematous skin patches with definite loss of sensation, thickened peripheral nerves, and acid fast bacilli detected on skin smears or biopsy material. M.leprae primarily infects Schwann cells in the peripheral nerves system leading to nerve damage and the development of disabilities.[1] Leprosy is a disease with crippling consequences, not only on the effected person and family but also on the society as a whole. It was considered incurable before the introduction of multi –drug therapy, popularly known as MDT. Detecting new cases and monitoring disabilities caused by leprosy will be a challenge.[2] The state of Ceará ranks 13th in number of cases of leprosy in Brazil, and fourth in Northeastern region, with an average of 2,149 new cases diagnosed every year. This study aimed to evaluate the knowledge of leprosy patients regarding treatment, and to assess the level of treatment adherence and its possible barriers. The study was conducted in the reference center for dermatology, from September 2010 to October 2010, in Fortaleza, Ceará. The study data were collected by means of a structured interview, along with the Morisky-Green test, in order to assess treatment adherence and barriers to adherence. A total of 70 patients were interviewed, out of whom 66 were new cases. The majority of patients were between 42 and 50 years old, and 37 (52.9%) were male. Most patients were clinically classified as presenting multibacillary leprosy (80%), and 78.6% of them were from Fortaleza, Brazil. The Morisky- Green test indicated that 62.9% of patients presented a low level of adherence (p < 0.005), despite claiming to aware of the disease risks. However, it was observed that 57.1% of the patients had no difficulty adhering to treatment, while 38.6% reported little difficulty. This study shows that despite the patients claiming to be familiar with leprosy and its treatment, the Morisky-Green test clearly demonstrated that they actually were not aware of the principles of therapy, which is evidenced by the low degree of treatment adherence.[26]
Authors and Affiliations
Rahul Chaurasiya
Keywords
Related Articles
- EP ID EP627025
- DOI -
- Views 130
- Downloads 0
AWARENESS ON THALASEMIA PREVENTION AND ITS TREATMENT IN COMMUNITY PRACTICE-A BRIEF REVIEW
Thalassemia is an inherited blood disorder in which the body makes an abnormal form of hemoglobin. Hemoglobin is the protein molecule in red blood cells that carries oxygen. The disorder results in excessive destruction...
AYURVEDA AND PSYCHOLOGY
The name Ayurveda was given to the ancient healing tradition of India. It is often translated as the "science of life," from ayus (life) and veda (knowledge). It is an ancient science of body, mind and spirit which has s...
REVIEW ON ANTICANCER ENZYMES AND THEIR TARGETED AMINO ACIDS
Cancer cells proliferate abnormally when compared to normal cells, as a result they require high amount of amino acids as nutrients because they are the building blocks for protein synthesis. Proteins are not only essent...
CYTOTOXICITY EVALUATIONS OF THE AQUEOUS EXTRACTS OF HERBAL MELANIN DRIVED FROM NIGELLA SATIVA SEEDS USING IN VIVO AND IN VITRO MODELS TESTS
Background: Many studies over millennia have been carried out to determine a widely used medicinal plant throughout the world. Of these, most of the therapeutic properties of Nigella sativa (N. sativa) seeds are due to t...
TEA AND COFFEE CONSUMPTION IN RELATION TO C-REACTIVE PROTEIN INFLAMMATORY MARKER AMONG HEALTHY SUDANESE POPULATION
In recent years, clinical and observational studies reported that coffee and tea consumption were associated with cardiac arrhythmia, heart rate, serum cholesterol, blood pressure, and consequently cardiovascular risk (M...